JP2025508389A5 - - Google Patents
Info
- Publication number
- JP2025508389A5 JP2025508389A5 JP2024547778A JP2024547778A JP2025508389A5 JP 2025508389 A5 JP2025508389 A5 JP 2025508389A5 JP 2024547778 A JP2024547778 A JP 2024547778A JP 2024547778 A JP2024547778 A JP 2024547778A JP 2025508389 A5 JP2025508389 A5 JP 2025508389A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- heavy chain
- light chain
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22156205.1A EP4227321A1 (en) | 2022-02-10 | 2022-02-10 | Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll |
| EP22156205.1 | 2022-02-10 | ||
| EP22156209.3 | 2022-02-10 | ||
| EP22156209 | 2022-02-10 | ||
| PCT/EP2023/053160 WO2023152204A1 (en) | 2022-02-10 | 2023-02-09 | Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508389A JP2025508389A (ja) | 2025-03-26 |
| JP2025508389A5 true JP2025508389A5 (https=) | 2026-02-18 |
Family
ID=85410412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547778A Pending JP2025508389A (ja) | 2022-02-10 | 2023-02-09 | 慢性リンパ性白血病のｂ細胞受容体を標的とする抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250145706A1 (https=) |
| EP (1) | EP4476264A1 (https=) |
| JP (1) | JP2025508389A (https=) |
| KR (1) | KR20250004625A (https=) |
| CN (1) | CN118984838A (https=) |
| CA (1) | CA3243736A1 (https=) |
| WO (1) | WO2023152204A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3262006A1 (en) * | 2022-07-25 | 2024-02-01 | Sinabiosolution Gmbh | Humanized chimeric antigen receptors targeting the B-lymphocyte receptor in chronic lymphocytic leukemia and their uses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| ATE375365T1 (de) | 1998-04-02 | 2007-10-15 | Genentech Inc | Antikörper varianten und fragmente davon |
| EP3424527A1 (de) | 2017-07-07 | 2019-01-09 | AVA Lifescience GmbH | Diagnostisches verfahren |
| WO2020127827A1 (de) * | 2018-12-20 | 2020-06-25 | Ava Lifescience Gmbh | Verfahren zur selektion biologischer bindemoleküle |
| CA3148214A1 (en) * | 2019-05-02 | 2020-11-05 | Ava Lifescience Gmbh | Antigent binding domains and uses therefor |
-
2023
- 2023-02-09 EP EP23707870.4A patent/EP4476264A1/en active Pending
- 2023-02-09 US US18/837,357 patent/US20250145706A1/en active Pending
- 2023-02-09 WO PCT/EP2023/053160 patent/WO2023152204A1/en not_active Ceased
- 2023-02-09 CA CA3243736A patent/CA3243736A1/en active Pending
- 2023-02-09 CN CN202380033174.5A patent/CN118984838A/zh active Pending
- 2023-02-09 KR KR1020247030426A patent/KR20250004625A/ko active Pending
- 2023-02-09 JP JP2024547778A patent/JP2025508389A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020536109A5 (https=) | ||
| JP2011506483A5 (https=) | ||
| JP2016528247A5 (https=) | ||
| JP2018512435A5 (https=) | ||
| TW201023855A (en) | Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan | |
| JP2009511480A5 (https=) | ||
| JP2003517461A5 (https=) | ||
| JP2012046518A5 (https=) | ||
| JP2015534578A5 (https=) | ||
| JP2017537893A5 (https=) | ||
| JP2018532715A5 (https=) | ||
| JP2005533001A5 (https=) | ||
| JP2014114288A5 (https=) | ||
| JP2021533204A5 (https=) | ||
| JP2006512899A5 (https=) | ||
| JP2016519650A5 (https=) | ||
| JP2014169326A5 (https=) | ||
| JP2021523100A5 (https=) | ||
| JP2013534515A5 (ja) | 受容体型チロシンキナーゼｃ−Ｍｅｔに対する抗体 | |
| JP2005505256A5 (https=) | ||
| JP2022536469A5 (https=) | ||
| WO2021231639A1 (en) | Use of a multimeric anti-dr5 binding molecule in combination with a cancer therapy for treating cancer | |
| JP2018512402A5 (https=) | ||
| RU2020112280A (ru) | Конъюгаты анти-egfr антитело-лекарственное средство (adc) и их применение | |
| JP2019521156A5 (https=) |